Diabetes: how to manage diabetic peripheral neuropathy

Area of Science:

• Neurology
• Endocrinology
• Pharmacology

Background:

• Diabetic peripheral neuropathy (DPN) is a significant complication of diabetes mellitus.
• Effective management strategies are crucial for preventing DPN and its associated symptoms.
• Limited evidence exists on the efficacy of glycemic control for established DPN symptoms, particularly pain.

Purpose of the Study:

• To review current therapeutic strategies for diabetic peripheral neuropathy.
• To highlight the role of pharmacological and non-pharmacological interventions in managing DPN.
• To emphasize the importance of optimizing treatment adherence and dosing for improved patient outcomes.

Main Methods:

• Review of current literature on DPN management.
• Analysis of pharmacological treatments, including first-line agents like anticonvulsants and antidepressants.
• Discussion of non-pharmacological interventions such as foot care and lifestyle modifications.

Main Results:

• Pharmacological agents are key for managing DPN pain, affecting 25-35% of patients.
• First-line medications include pregabalin, gabapentin, duloxetine, venlafaxine, nortriptyline, and desipramine.
• Suboptimal dosing and poor adherence are common, leading to inadequate symptom management and treatment discontinuation.

Conclusions:

• Optimizing medication dosage and adherence is critical for effective DPN symptom control.
• Healthcare professionals must stay updated on the latest treatment algorithms for DPN.
• Improved management strategies can enhance the quality of care for individuals with diabetic peripheral neuropathy.